Received May 25, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | — |
Abdominal cramps; nausea; fever; felt like another case of COVID; sick to stomach; This non-serious case was reported by a consumer via sales rep and described the occurrence of abdominal cramp in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced abdominal cramp (Verbatim: Abdominal cramps), nausea (Verbatim: nausea), fever (Verbatim: fever), viral infection (Verbatim: felt like another case of COVID) and gastric disorder (Verbatim: sick to stomach). The outcome of the abdominal cramp, nausea, fever, viral infection and gastric disorder were resolved. The reporter considered the abdominal cramp, nausea, fever, viral infection and gastric disorder to be related to Shingrix. The company considered the abdominal cramp, nausea, fever, viral infection and gastric disorder to be related to Shingrix. Additional Information: GSK Receipt Date: 21-MAY-2026 The patient did not get the 2nd dose to complete the series. The batch number was not provided and a request for this information has been made.